Tazemetostat

Introduction: What is Tazemetostat?

Tazemetostat is a targeted therapy medication primarily used in the treatment of certain types of cancer, unresectable epithelioid sarcoma, and follicular lymphoma. It is classified as an EZH2 inhibitor, which means it works by blocking the activity of the EZH2 protein, a key player in the regulation of gene expression. By inhibiting this protein, Tazemetostat can help slow down or stop the growth of cancer cells.

Uses of Tazemetostat

Tazemetostat has been approved for specific medical uses, including:

• Epithelioid Sarcoma: A rare and aggressive form of soft tissue cancer, tazemetostat is used in patients who have unresectable locally advanced or metastatic disease and who have no satisfactory alternative treatment options.
• Follicular Lymphoma: This is a type of non-Hodgkin lymphoma. Tazemetostat is indicated for adult patients with relapsed or refractory follicular lymphoma whose tumors are positive for an EZH2 mutation as detected by an FDA-approved test and who have received at least 2 prior systemic therapies.

How Does It Work?

Tazemetostat works by inhibiting the EZH2 protein, which is involved in the process of gene silencing. In cancer cells, EZH2 is often overactive, leading to the silencing of genes that would normally suppress tumor growth. By blocking EZH2, Tazemetostat helps to reactivate these tumor-suppressing genes, thereby slowing down the proliferation of cancer cells and potentially leading to tumor shrinkage.

Dosage and Administration

Tazemetostat is typically administered in tablet form. The standard dosage for adults is 800 mg taken orally twice daily. For pediatric patients aged 16 years and older with epithelioid sarcoma, the dosage is based on body surface area (BSA): 520 mg/m? orally twice daily (not to exceed 800 mg/dose). No specific dosing for patients under 16 years. It is important to take Tazemetostat at the same time each day to maintain consistent levels of the medication in the body.

Side Effects of Tazemetostat

Like all medications, Tazemetostat can cause side effects.

Common side effects include:

• Fatigue
• Nausea
• Vomiting
• Diarrhea
• Rash
• Fever
• Decreased appetite

Serious side effects may include:

• Drug-induced hepatotoxicity (elevated liver enzymes)
• Secondary malignancies (e.g., T-cell lymphoproliferative disorder, myelodysplastic syndrome)
• Myelosuppression (e.g., neutropenia, thrombocytopenia)
• Severe allergic reactions
• Blood disorders (such as low blood cell counts)

Patients should report any unusual symptoms to their healthcare provider promptly.

Drug Interactions

Tazemetostat may interact with several medications, which can affect how it works or increases the risk of side effects. Major drug interactions include:

• Strong CYP3A inhibitors (e.g., itraconazole) increase tazemetostat exposure; avoid or reduce dose.
• Strong CYP3A inducers (e.g., rifampin) decrease exposure; avoid.
• OATP1B1 inhibitors (e.g., atazanavir) may increase exposure.

Always inform your healthcare provider about all the medications and supplements you are taking to avoid potential interactions.

Benefits of Tazemetostat

The clinical advantages of Tazemetostat include:

• Targeted therapy: It specifically targets cancer cells with EZH2 mutations, potentially leading to better outcomes with fewer side effects compared to traditional chemotherapy.
• Oral administration: The convenience of taking a pill rather than undergoing injections or infusions.
• Efficacy in difficult-to-treat cancers: It provides a treatment option for patients with limited alternatives, particularly in rare cancers like epithelioid sarcoma.

Contraindications of Tazemetostat

There are no absolute contraindications. Use caution in pregnancy (Embryo-Fetal Toxicity black box warning: can cause fetal harm; verify pregnancy status and use effective contraception). Avoid in breastfeeding (discontinue nursing).

Precautions and Warnings

Before starting Tazemetostat, patients should undergo liver function tests to ensure their liver is functioning properly. Regular monitoring may be necessary during treatment to check for any adverse effects, particularly liver-related issues. Patients should also be aware of the signs of allergic reactions and report them immediately. Monitor for secondary malignancies and hematologic toxicity with regular CBCs. Boxed warning for secondary malignancies.

FAQs

• What is Tazemetostat used for? Tazemetostat is used to treat certain types of cancer, including epithelioid sarcoma and follicular lymphoma.
• How is Tazemetostat taken? It is taken orally in tablet form, typically 800 mg twice daily.
• What are the common side effects? Common side effects include fatigue, nausea, vomiting, diarrhea, and rash.
• Can Tazemetostat be taken with other medications? Some medications may interact with Tazemetostat. Always consult your doctor before combining treatments.
• Is Tazemetostat safe during pregnancy? No, it is contraindicated in pregnant women due to potential risks to the fetus.
• How does Tazemetostat work? It inhibits the EZH2 protein, which helps reactivate tumor-suppressing genes, slowing cancer growth.
• What should I do if I miss a dose? Take the missed dose as soon as you remember but skip it if it's almost time for your next dose. Do not double up.
• Are there any serious side effects? Yes, serious side effects can include liver problems and severe allergic reactions.
• How long will I need to take Tazemetostat? Treatment duration varies based on individual response and should be discussed with your healthcare provider.
• Can I drink alcohol while taking Tazemetostat? No data; consult provider, as alcohol may affect liver function.

Brand Names

Tazemetostat is marketed under the brand name Tazverik.

Conclusion

Tazemetostat represents a significant advancement in the treatment of specific cancers, offering targeted therapy options for patients with limited alternatives. Its mechanism of action, dosage regimen, and potential side effects are important considerations for both patients and healthcare providers. As with any medication, it is crucial to consult with a healthcare professional to determine the best treatment plan tailored to individual needs.